... gained momentum much faster than company officials expected. In January 2014, Geisinger and research partner, the Tarrytown, New York-based Regeneron Pharmaceuticals, set out to sequence 100,000 human exomes - the protein-rich portion of the genome ...
http://ift.tt/1YXgIvv
No comments:
Post a Comment